---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008988"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:02:43.846942+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel announces 1-for-16 reverse stock split effective May 12, 2025 to meet Nasdaq bid price requirement

## Summary
- Reverse split ratio of 1-for-16; effective May 12, 2025 at market open.
- Pre-split shares: 356,357,531; post-split shares: 22,272,346 (rounded).
- No fractional shares; rounding rules apply for shares half or more/less than half.
- CUSIP changes to 23254L884; trading symbol remains CYCC on Nasdaq Capital Market.
- Split approved by board and stockholders to regain compliance with Nasdaq minimum bid price.

## SEC filing metadata
- accession: 0001641172-25-008988
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000164117225008988/0001641172-25-008988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000164117225008988/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008988
- JSON: https://secwatch.observer/filing/0001641172-25-008988.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.